Free Trial

Lipella Pharmaceuticals (LIPO) SEC Filings & 10K Form

Lipella Pharmaceuticals logo
$2.52 0.00 (0.00%)
Closing price 03:59 PM Eastern
Extended Trading
$2.50 -0.02 (-0.99%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Lipella Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/01/2025
8:19 PM
Huang Leaf (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
04/14/2025
5:08 AM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2025
7:39 PM
Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
04/09/2025
7:43 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
04/09/2025
4:06 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/07/2025
6:16 PM
Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
6:20 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
04/07/2025
5:05 AM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2025
4:14 PM
Lipella Pharmaceuticals (Filer)
Form 424B5
04/03/2025
11:15 PM
Lipella Pharmaceuticals (Filer)
Form EFFECT
03/28/2025
5:21 AM
Lipella Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/27/2025
6:56 PM
Lipella Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/19/2025
5:23 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
03/18/2025
4:01 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2025
7:18 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
03/17/2025
7:12 PM
Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:01 PM
Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:09 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
03/11/2025
4:26 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/24/2025
3:05 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2025
8:28 AM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2025
4:32 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
02/10/2025
4:35 PM
Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/30/2025
4:27 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/30/2025
4:28 PM
Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/23/2025
5:08 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/23/2025
5:11 PM
Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/17/2025
7:13 PM
Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
7:17 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/16/2025
5:51 AM
Lipella Pharmaceuticals (Filer)
Form 424B3
01/15/2025
11:15 PM
Lipella Pharmaceuticals (Filer)
Form EFFECT
01/13/2025
7:42 AM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
4:25 PM
Lipella Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/07/2025
4:28 PM
Lipella Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
01/06/2025
4:25 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2025
8:22 PM
Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
8:25 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
12/30/2024
3:11 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
8:28 PM
Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
8:31 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
12/27/2024
3:05 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Trump Makes Major Crypto Announcement (Ad)

Trump's Pro-Crypto Agenda Finally Sparks Market Recovery With Bitcoin surging past $90,000 and altcoins heating up, I'm seeing all the signs of a major market shift For a limited time, I'm revealing the name and complete analysis behind my top Trump-era crypto pick.

12/10/2024
8:29 AM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:26 PM
Lipella Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
4:01 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
4:24 PM
Lipella Pharmaceuticals (Filer)
Form PRE 14A
11/01/2024
4:00 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2024
3:05 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
4:00 PM
Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SC 13D/A
10/17/2024
4:00 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SC 13D/A
09/11/2024
4:10 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
3:05 PM
Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SC 13D/A
08/13/2024
3:13 PM
Lipella Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
7:44 AM
Lipella Pharmaceuticals (Filer)
Form ARS
08/12/2024
7:25 AM
Lipella Pharmaceuticals (Filer)
Form DEF 14A
08/06/2024
3:50 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
4:20 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
10:50 AM
Lipella Pharmaceuticals (Filer)
Form 424B5
05/15/2024
3:39 PM
Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:LIPO) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners